Intervention in growth factor activated signaling pathways by renally targeted kinase inhibitors
- 18 December 2008
- journal article
- research article
- Published by Elsevier in Journal of Controlled Release
- Vol. 132 (3), 200-207
- https://doi.org/10.1016/j.jconrel.2008.08.013
Abstract
No abstract availableKeywords
This publication has 24 references indexed in Scilit:
- Novel Therapeutic Targets for the Treatment of Tubulointerstitial FibrosisCurrent Signal Transduction Therapy, 2008
- Bone Morphogenetic Protein-7 and Connective Tissue Growth Factor: Novel Targets for Treatment of Renal Fibrosis?Pharmaceutical Research, 2008
- Regulation of Dedifferentiation and Redifferentiation in Renal Proximal Tubular Cells by the Epidermal Growth Factor ReceptorJournal of Pharmacology and Experimental Therapeutics, 2008
- Organ- and Cell-Type Specific Delivery of Kinase Inhibitors: A Novel Approach in the Development of Targeted DrugsCurrent Molecular Pharmacology, 2008
- A New Look at Platelet-Derived Growth Factor in Renal DiseaseJournal of the American Society of Nephrology, 2008
- Uncovering Pandora’s vase: the growing problem of new toxicities from novel anticancer agents. The case of sorafenib and sunitinibClinical and Experimental Medicine, 2007
- Epidermal growth factor and transforming growth factor-β1 enhance HK-2 cell migration through a synergistic increase of matrix metalloproteinase and sustained activation of ERK signaling pathwayExperimental Cell Research, 2007
- Erlotinib in cancer treatmentAnnals of Oncology, 2007
- Angiotensin II and EGF receptor cross-talk in chronic kidney diseases: a new therapeutic approachNature Medicine, 2005
- Specific Drug Delivery to the KidneyCardiovascular Drugs and Therapy, 2002